
Biosimilar – Patent Dance
A biosimilar is a biologic product similar to another already approved biological medicine (known as ‘reference medicine’). The biosimilar (complex molecules) is not a generic product of a biological medicine in comparison to pharmaceutical generic medicines (small molecules) because the biosimilar exhibits natural variability and complex manufacturing that do not allow an exact replication of […]